These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28126969)

  • 21. Strategies to overcome resistance mutations of Bruton's tyrosine kinase inhibitor ibrutinib.
    Liu L; Shi B; Wang X; Xiang H
    Future Med Chem; 2018 Feb; 10(3):343-356. PubMed ID: 29347836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulatory effects of beta-glucan on neutrophil function in fathead minnows (Pimephales promelas Rafinesque, 1820).
    Palić D; Andreasen CB; Herolt DM; Menzel BW; Roth JA
    Dev Comp Immunol; 2006; 30(9):817-30. PubMed ID: 16423394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia.
    Bizargity P; Adigüzel C; Ozilhan G; Bayik M; Eksioglu-Demiralp E
    Clin Lab Haematol; 2005 Feb; 27(1):79-80. PubMed ID: 15686514
    [No Abstract]   [Full Text] [Related]  

  • 24. The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation.
    Reiff SD; Mantel R; Smith LL; Greene JT; Muhowski EM; Fabian CA; Goettl VM; Tran M; Harrington BK; Rogers KA; Awan FT; Maddocks K; Andritsos L; Lehman AM; Sampath D; Lapalombella R; Eathiraj S; Abbadessa G; Schwartz B; Johnson AJ; Byrd JC; Woyach JA
    Cancer Discov; 2018 Oct; 8(10):1300-1315. PubMed ID: 30093506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,7-dimethoxy-4H-chromen-4-one (MSF-2) suppresses fMLP-mediated respiratory burst in human neutrophils by inhibiting phosphatidylinositol 3-kinase activity.
    Liao CH; Chen JJ; Lin JE; Liu CH; Tseng CP; Day YJ
    J Cell Physiol; 2011 Jun; 226(6):1519-30. PubMed ID: 20945388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of genotype in activation and priming of the respiratory burst in neutrophils.
    Gabdulkhakova AG; Safronova VG; Sadovnikov VB
    Dokl Biochem; 2000; 372(1-6):73-6. PubMed ID: 10935168
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors.
    Jain P; Kanagal-Shamanna R; San Lucas FA; Nastoupil L; Romaguera J; Fayad L; Oki Y; Westin JR; Medeiros LJ; Wang M; Fowler N
    Br J Haematol; 2018 Sep; 182(5):718-723. PubMed ID: 28771675
    [No Abstract]   [Full Text] [Related]  

  • 28. Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.
    Del Papa B; Baldoni S; Dorillo E; De Falco F; Rompietti C; Cecchini D; Cantelmi MG; Sorcini D; Nogarotto M; Adamo FM; Mezzasoma F; Silva Barcelos EC; Albi E; Iacucci Ostini R; Di Tommaso A; Marra A; Montanaro G; Martelli MP; Falzetti F; Di Ianni M; Rosati E; Sportoletti P
    Clin Cancer Res; 2019 Dec; 25(24):7540-7553. PubMed ID: 31578228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement-induced impairment of innate immunity during sepsis.
    Huber-Lang MS; Younkin EM; Sarma JV; McGuire SR; Lu KT; Guo RF; Padgaonkar VA; Curnutte JT; Erickson R; Ward PA
    J Immunol; 2002 Sep; 169(6):3223-31. PubMed ID: 12218141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early events in the activation of Fc gamma RIIA in human neutrophils: stimulated insolubilization, translocation to detergent-resistant domains, and degradation of Fc gamma RIIA.
    Barabé F; Rollet-Labelle E; Gilbert C; Fernandes MJ; Naccache SN; Naccache PH
    J Immunol; 2002 Apr; 168(8):4042-9. PubMed ID: 11937562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Src kinases regulate PKB activation and modulate cytokine and chemoattractant-controlled neutrophil functioning.
    Nijhuis E; Lammers JW; Koenderman L; Coffer PJ
    J Leukoc Biol; 2002 Jan; 71(1):115-24. PubMed ID: 11781387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.
    Niemann CU; Herman SE; Maric I; Gomez-Rodriguez J; Biancotto A; Chang BY; Martyr S; Stetler-Stevenson M; Yuan CM; Calvo KR; Braylan RC; Valdez J; Lee YS; Wong DH; Jones J; Sun C; Marti GE; Farooqui MZ; Wiestner A
    Clin Cancer Res; 2016 Apr; 22(7):1572-82. PubMed ID: 26660519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions.
    Series J; Garcia C; Levade M; Viaud J; Sié P; Ysebaert L; Payrastre B
    Haematologica; 2019 Nov; 104(11):2292-2299. PubMed ID: 30819914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes.
    Bouchon A; Dietrich J; Colonna M
    J Immunol; 2000 May; 164(10):4991-5. PubMed ID: 10799849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of volatile anaesthetics on human neutrophil oxidative response to the bacterial peptide FMLP.
    Fröhlich D; Rothe G; Schwall B; Schmid P; Schmitz G; Taeger K; Hobbhahn J
    Br J Anaesth; 1997 Jun; 78(6):718-23. PubMed ID: 9215026
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumour necrosis factor-alpha potentiates CR3-induced respiratory burst by activating p38 MAP kinase in human neutrophils.
    Forsberg M; Löfgren R; Zheng L; Stendahl O
    Immunology; 2001 Aug; 103(4):465-72. PubMed ID: 11529937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Perfluorocarbon emulsions and other corpuscular systems influence on neutrophil activity].
    Shekhtman DG; Safronova VG; Sklifas AN; Alovskaia AA; Gapeev AB; Obraztsov VV; Chemeris NK
    Biofizika; 1997; 42(6):1260-6. PubMed ID: 9490112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting protein kinase C in mantle cell lymphoma.
    Rauert-Wunderlich H; Rudelius M; Ott G; Rosenwald A
    Br J Haematol; 2016 May; 173(3):394-403. PubMed ID: 26914495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of red blood cell lysing solutions in the study of neutrophil oxidative burst by the DCFH assay.
    Vuorte J; Jansson SE; Repo H
    Cytometry; 2001 Apr; 43(4):290-6. PubMed ID: 11260596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pravastatin prevents miscarriages in antiphospholipid antibody-treated mice.
    Girardi G
    J Reprod Immunol; 2009 Nov; 82(2):126-31. PubMed ID: 19556010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.